Skip to content
Screener

Rigel Pharmaceuticals RIGL Free cash flow margin

Discontinued — last reported Q4 '22

Free cash flow margin at other companies

Amgen logo
AmgenAMGN
26.7%-3.7pp
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
-371.4%-143pp
Nuvation Bio logo
Nuvation BioNUVB
-75.7%-36.6pp
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
-75%-30.5pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
-5.1%—
Opko Health logo
Opko HealthOPK
-22.8%-6.7pp

Other financials

Income statement

See full
Revenue$58.8M+10.3%
Gross profit$54.2M+10.8%
Operating income$11.9M-7.0%
Net income$8.7M-24.4%
EPS (diluted)$0.44-30.2%

Balance sheet

See full
Cash & equivalents$24.5M-46.6%
Total debt$68.4M+5,079%
Total equity$399.9M+2,054%
Total assets$504.6M+187%

Cash flow

See full
Operating cash flow$2.7M+405%
CapEx$73.0K—
Free cash flow-$22.0M—

Valuation

See full
Market cap$750.37M+25.0%
Enterprise value$794.27M+44.9%
P/E2.1×-4.1×
P/S2.5×+0.3×

Profitability

See full
Gross margin93.4%+3.7pp
Operating margin41.6%+19.9pp
Net margin121.5%+103pp

Returns & leverage

See full
Return on equity174.1%—
Debt / equity0.2×+0.1×
Current ratio2.6×+0.4×

Where this comes from

Calculated from Rigel Pharmaceuticals’s reported figures.

free cash flow/total revenue=-61.7%

Based on trailing twelve months.

The source filing: Rigel Pharmaceuticals’s 10-K, filed March 3, 2026. Open the filing →

Filed
Mar 3, 2026, 4:06 PM EST
Fiscal year
FY2025
Accession
0001034842-26-000015

FAQ

What is Rigel Pharmaceuticals's free cash flow margin?
Rigel Pharmaceuticals (RIGL) reported free cash flow margin of -61.7% in Q4 2022.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

Ask your AI about Rigel Pharmaceuticals's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude